Ordinary Index Rebalancing in the Solactive Global Vaccines and Infectious Diseases Index | February 2022

In the ordinary rebalance the following composition will be implemented effective open 14.02.2022:

3SBIO INC
ADAPTIVE BIOTECHNOLOGIES CORP
ASTRAZENECA PLC
BIONTECH SE
CANSINO BIOLOGICS INC
CUREVAC BV
DYNAVAX TECHNOLOGIES CORP
ELI LILLY & CO
EMERGENT BIOSOLUTIONS INC
GLAXOSMITHKLINE PLC
IMMUNITYBIO INC
IMUGENE LTD
INOVIO PHARMACEUTICALS INC
JOHNSON & JOHNSON
LABORATORY CRP OF AMER HLDGS
MARAVAI LIFESCIENCES HOLDINGS INC
MERCK & CO. INC.
MODERNA INC
NOVAVAX INC
OPKO HEALTH INC
PFIZER INC
QUEST DIAGNOSTICS INC
QUIDEL CORP
REGENERON PHARMACEUTICALS
SANOFI SA
SHANGHAI JUNSHI BIOSCIENCES CO LTD
SORRENTO THERAPEUTICS INC
VALNEVA SE
VAXCYTE INC
VIR BIOTECHNOLOGY INC